Search

everythinglearnresearchcommunity

for

Search:↓

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Certain hormone treatments can improve acne and related conditions in women.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

The document concludes that more research is needed to fully understand the causes of PCOS.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.